Guidelines for NHL: Updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia Journal Article


Author: Zelenetz, A. D.
Article Title: Guidelines for NHL: Updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia
Abstract: During his presentation at the NCCN 19th Annual Conference, Dr. Andrew D. Zelenetz reviewed the updates to the 2014 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Hodgkin's Lymphomas. Dr. Zelenetz first discussed the updates for diffuse large B-cell lymphoma (DLBCL), focusing primarily on the emergence of MYC-positive DLBCL; the limited role of imaging in early-stage disease; new treatment options; the challenge of tumor heterogeneity; and the impact of cell of origin in the selection of future therapies. Then, on behalf of Dr. Steven Horwitz, Dr. Zelenetz presented the new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia. © JNCCN-Journal of the National Comprehensive Cancer Network.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 12
Issue: 5 Suppl.
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2014-05-01
Start Page: 797
End Page: 800
Language: English
PROVIDER: scopus
PUBMED: 24853220
DOI/URL:
Notes: JNCCN J. Nat. Compr. Cancer Netw. -- Export Date: 8 July 2014 -- Source: Scopus
Citation Impact
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz
Related MSK Work